Name | 4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol |
Synonyms | FAAH-IN-2 Gefitinib Intermediate 1 Gefitinib interMediate VII O-Desmorpholinopropyl Gefitinib 4-(3-Chlor-4-fluorophenylamino)-7-methoxyquinazolin-6-ol 4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol 4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol 4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinol 4-(3-Chloro-4-fluorophenylamino)-6-hydroxy-7-methoxyquinazoline |
CAS | 184475-71-6 |
EINECS | 1806241-263-5 |
InChI | InChI=1/C15H11ClFN3O2/c1-22-14-6-12-9(5-13(14)21)15(19-7-18-12)20-8-2-3-11(17)10(16)4-8/h2-7,21H,1H3,(H,18,19,20) |
Molecular Formula | C15H11ClFN3O2 |
Molar Mass | 319.72 |
Density | 1.489±0.06 g/cm3(Predicted) |
Melting Point | >260°C (dec.) |
Boling Point | 478.8±45.0 °C(Predicted) |
Flash Point | 243.375°C |
Solubility | DMSO (Slightly), Methanol (Very Slightly, Heated) |
Vapor Presure | 0mmHg at 25°C |
Appearance | tawny solid |
Color | Pale Beige to Beige |
pKa | 8.18±0.40(Predicted) |
Storage Condition | Keep in dark place,Inert atmosphere,Store in freezer, under -20°C |
Refractive Index | 1.702 |
Use | Gefitinib Intermediate |
biological activity | FAAH-IN-2 (O-Desmorpholinopropyl Gefitinib) is a FAAH inhibitor taken from patent WO/2008/100977A2. |
Use | Gefitinib Intermediate |